Growth inhibitory effects of thromboxane antagonists on breast cancer cell lines: A preliminary study

Advances in Experimental Medicine and Biology

Volumn 400, Issue A, 1997, Pages 455-460

  Marshall, Kay ^a   Lane, Kate ^a   Senior, Judith ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN RECEPTOR; GLUCOCORTICOID; PROGESTERONE; THROMBOXANE; THROMBOXANE RECEPTOR BLOCKING AGENT;

BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CHEMICAL STRUCTURE; CONFERENCE PAPER; DNA SYNTHESIS; ESTRADIOL BLOOD LEVEL; GROWTH INHIBITION; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDRAZINES; PHENYLACETATES; PROSTAGLANDINS, SYNTHETIC; SULFONAMIDES; THROMBOXANES; TUMOR CELLS, CULTURED;

EID: 0031421243     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5325-0_61     Document Type: Article

References (11)

1. Armstrong, R.A., Jones, R.L. and Wilson, N.H. Prostaglandins 29:703-13, 1985.
2. Brooks, S.C.; Locke, E.R. and Soule, H.D. J. Biol. Chem. 248:6251-6253, 1973.
3. Butler, W.B., Kerr, M. Lane, K.E., Marshall, K. and Senior, J. (1992) N.I.C.E., Nice, France.
4. Berthois, T., Katenellenbogen, J.A. and Katzenellenbogen, B.S. Proc. Acad. Natl. Sci. 83:2496-2500, 1986.
5. Hedberg, A., Hall, S.E., Ogletree, M.L., Harris, D.N. and Liu, E.C. J. Pharmacol. Exp. Ther. 245:786-792, 1988.
6. Horwitz, K.B., Costlaw, M.E. and McGuire, W.L. Steroids 26:785-795, 1975.
7. Lefer, A.M. Drugs Future b13:999-1005, 1988.
8. Lippman, M.E and Bolan, G. Nature 256:592-593, 1975.
9. Osborne, C.K., Monaco, M.E., Lippman, M.E. and Kahn, C.R. Cancer Res. 38:94-102, 1978.
10. Senior, J. and Troughton, K. Br. J. Pharmacol 81:73, 1984.
11. Soule, H.D., Valquez, J., Long, A., Albert, S. and Brennan, M. J.N.C.I. 51:1409, 1973.